Alimera Sciences Stock Earnings Per Share
Alimera Sciences fundamentals help investors to digest information that contributes to Alimera Sciences' financial success or failures. It also enables traders to predict the movement of Alimera Stock. The fundamental analysis module provides a way to measure Alimera Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alimera Sciences stock.
Alimera |
Alimera Sciences Company Earnings Per Share Analysis
Alimera Sciences' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Alimera Sciences Earnings Per Share | 1.05 X |
Most of Alimera Sciences' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alimera Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Alimera Sciences has an Earnings Per Share of 1.05 times. This is 87.46% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The earnings per share for all United States stocks is 66.35% higher than that of the company.
Alimera Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alimera Sciences' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics of similar companies.Alimera Sciences is currently under evaluation in earnings per share category among its peers.
Alimera Fundamentals
Return On Equity | -0.35 | |||
Return On Asset | 0.0098 | |||
Profit Margin | (0.15) % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 360.44 M | |||
Shares Outstanding | 54.38 M | |||
Shares Owned By Insiders | 5.34 % | |||
Shares Owned By Institutions | 86.54 % | |||
Number Of Shares Shorted | 578.49 K | |||
Price To Earning | 1.65 X | |||
Price To Book | 7.77 X | |||
Price To Sales | 3.02 X | |||
Revenue | 80.75 M | |||
Gross Profit | 52 M | |||
EBITDA | 7.28 M | |||
Net Income | (20.13 M) | |||
Cash And Equivalents | 7.86 M | |||
Cash Per Share | 1.12 X | |||
Total Debt | 67.4 M | |||
Current Ratio | 1.30 X | |||
Book Value Per Share | 0.74 X | |||
Cash Flow From Operations | (14.26 M) | |||
Short Ratio | 1.93 X | |||
Earnings Per Share | 1.05 X | |||
Target Price | 5.67 | |||
Number Of Employees | 154 | |||
Beta | 1.25 | |||
Market Capitalization | 301.29 M | |||
Total Asset | 153.52 M | |||
Retained Earnings | (418.49 M) | |||
Working Capital | 30.51 M | |||
Current Asset | 51.6 M | |||
Current Liabilities | 7.85 M | |||
Net Asset | 153.52 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |